An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
<p><b>Background:</b> The aim of this thesis was to develop an evidence-based approach to the post-marketing withdrawal of medicinal products when harms are attributed to their use. </p> <p><b>Methods:</b> Electronic and non-electronic searches were conducte...
Հիմնական հեղինակ: | Onakpoya, I |
---|---|
Այլ հեղինակներ: | Heneghan, C |
Ձևաչափ: | Թեզիս |
Լեզու: | English |
Հրապարակվել է: |
2017
|
Խորագրեր: |
Նմանատիպ նյութեր
-
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
: Stefania Chiappini, և այլն
Հրապարակվել է: (2020-02-01) -
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
: Onakpoya, I, և այլն
Հրապարակվել է: (2016) -
The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
: Łukasz Dobrek
Հրապարակվել է: (2022-08-01) -
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
: Onakpoya, IJ, և այլն
Հրապարակվել է: (2016) -
Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
: Igho J. Onakpoya, և այլն
Հրապարակվել է: (2019-03-01)